2024 Sponsors
If you are interested in showcasing your company’s services to senior clinical development executives from Chinese and US BioPharmas, please contact: jon.liong@lycheegroup.com.
-
Novotech
Founded in 1997, Novotech is a global full-service clinical Contract Research Organization (CRO) focused on partnering with biotech companies to accelerate the development of advanced and novel therapeutics at every phase.
Recognized for its industry-leading contributions, Novotech has received numerous prestigious awards, including the Frost &Sullivan 2024 Global Biotech CRO Award, 2024 Employer of Choice, 2024 Great Place to Work in the US, 2024 Brandon Hall Gold Award, CRO Leadership Award 2023, the Asia Pacific Cell & Gene Therapy Clinical Trials Excellence 2023, the Asia-Pacific Contract Research Organization Company of the Year Award since 2006.
The Company offers a comprehensive suite of services including laboratories, Phase I facilities, drug development consulting, regulatory expertise, and has experience with over 5,000 clinical projects, including Phase I to Phase IV clinical trials and bioequivalence studies. With a presence in 34 office locations and a dedicated team of 3,000+ professionals worldwide, Novotech is a trusted end-to-end strategic partner of choice.
Platinum Sponsor
-
MERIT
MERIT is a global clinical trial endpoint services provider offering reliable and attentive expertise in our therapeutic areas. Our decades of experience allow us to hit the ground running on your project. You can feel confident in our proven track record; MERIT has supported twelve of the top twenty global pharmaceutical companies. Our clients rely on us as a trusted R&D partner.
-
PPD
The PPD™ clinical research business of Thermo Fisher Scientific is a leading provider of global CRO solutions. We provide comprehensive drug development, laboratory and lifecycle services to customers across pharmaceutical, biotechnology, medical device, academic and government entities. With more than 35,000 professionals worldwide, we have conducted clinical trials in more than 125 countries to help customers deliver life-changing therapies to improve health. By harnessing innovative technology and expertise, we work to empower our customers to bring therapies to market faster. For more information, visit thermofisher.com/ppd.
-
Thermo Fisher
Thermo Fisher Scientific provides industry-leading pharma services solutions for drug development, clinical trial logistics, and commercial manufacturing to customers through our Patheon brand. With more than 65 locations around the world, we provide integrated, end-to-end capabilities across all phases of development, including API, biologics, viral vectors, CTX, formulation, clinical trials solutions, logistics services, and commercial manufacturing and packaging. Built on a reputation for scientific and technical excellence, we provide pharma and biotech companies of all sizes instant access to a global network of facilities and experts across the Americas, Europe, Asia, and Australia. We offer integrated drug development and clinical services tailored to fit your drug development journey through our Quick to Care™ program. Our Quick to Clinic™ programs for large and small molecules help you balance speed and risk during early development so that you can file your IND quickly and successfully. Digital innovations such as our mysupply Platform and Pharma 4.0 enablement offer real-time data and a streamlined experience. Together with our customers, we’re rapidly turning pharmaceutical possibilities into realities.
www.thermofisher.cn l www.thermofisher.com/patheon-cn
Gold Sponsors
-
PSI CRO
PSI is a unique global CRO with offices and an operational presence of full-time operational staff in more than 50 countries. PSI is headquartered in Switzerland and is fully owned by the management team that created the company in 1995.
PSI is known for its commitment to delivery and service, focus on global pivotal phase II and III trials, as well as exceptionally high repeat business rates.
Biotech and pharma clients that work with PSI on global trials tend to stay with them for decades, which explains the company's stability and steady organic growth supported by exceptionally low staff turnover rates.
PSI's mission is to be the best CRO in the world as measured by their employees, clients, investigators, and vendors.
-
Taimei Technology
Taimei Technology (HK.2576) is a digital intelligence platform for the life science industry. Our business encompasses drug research and development (R&D), pharmacovigilance, marketing and sales, and other related fields. With collaboration as the core concept, AI empowerment, the company has built the innovative Trials—Intelligent Clinical Research Collaboration Platform and Wujie— Interaction Platform, integrating more than 20 SaaS products. The collaborative platform connects various stakeholders in the industry, including pharmaceutical companies, hospitals, third-party service providers (CRO, SMO, etc.), regulatory agencies, and patients. Meanwhile, in combination with the advanced technologies like artificial intelligence, big data, and cloud computing, the collaborative platform ensures consistent standards, seamless data flow, collaborative processes, and integrated resources. In this way, the efficiency in drug R&D and commercial performance are greatly enhanced, while achieving value upgrade and win-win results for multiple parties involved.
To date, Taimei Technology has successfully provided digital solutions to over 1,400 pharmaceutical companies and Contract Research Organizations (CROs), and more than 700 hospitals. The company has also expanded its business to overseas regions including the Asia Pacific, North America, and the European Union. The company holds a leading market position, as evidenced by the the Technical Solution Market for Life Science Industry report published Frost & Sullivan. The 2019-2022 IDC series reports on the Market Share of Clinical Trial Information System Solutions in China showed that the company ranked first in the market share of clinical trial information system solutions in China.
Taimei Technology is dedicated to its mission of "Making Health Accessible through the Power of Digitalization." In pursuit of this mission, we are establishing the infrastructure for the future of the biopharma industry to ensure faster product launches, enhanced drug safety, improved drug accessibility and a reduced medical burden.
Silver Sponsors
-
Agilex Biolabs
Agilex Biolabs is the largest and most technologically advanced regulated bioanalytical and toxicology laboratory in Australia. In our 28 years of performing regulated bioanalysis of small and large molecules, we have accelerated hundreds of preclinical and clinical trials around the world.
As a global leader in providing flexible solutions, Agilex Biolabs has accelerated numerous drug development programs from US, APAC and EU. In addition to working with Agilex, you can enjoy the Australian advantage including quick start-up for early phase trials, regulatory speed and R&D Tax rebate (43.5%) .
Our service:
1.Pharmacokinetic (PK) analysis
- Biologics,
- Small molecules (17x LC-MS/MS),
- Biosimilars
- Vaccine studies
- Oligo studies
2.Pharmacodynamics (PD) analysis
- Biomarker solutions (MSD, ELISA, Flow cytometry, ddPCR, Elispot etc)
- Immunogenicity studies,
- Cell based assays (RO, ADA, Immunophenotyping, etc)
- Vaccine studies
- Oligo studies
3.GLP/Non-GLP Toxicology
-
Almac
For over 25 years Almac Clinical Technologies group has been leading the Interactive Response Technology industry with over 700 clients and 4000 trials, bringing together the most innovative technology and our unparalleled expertise to empower biopharmaceutical industry and help bring new therapies to patients.
-
Catalent
Catalent is a global leader in clinical supply services, with comprehensive and flexible solutions for small molecules, biologics, and cell and gene therapies and integrated solutions to accelerate speed to clinic. Catalent offers a full range services including clinical supply management, comprehensive packaging solutions, comparator sourcing, cold chain storage and global distribution and specialized supply chain services including direct-to-patient and demand-led supply. With nine GMP clinical packaging facilities and over 50 strategically located depots on six continents combined with more than 25 years’ experience across thousands of studies in more than 80 countries. Catalent has the comprehensive services, global scale and expertise necessary to reliably supply clinical trials of all sizes and complexity anywhere in the world.
china.catalent.com / clinical.catalent.com
-
CMAX Clinical Research
CMAX Clinical Research has been a leader in early phase clinical trials for 31 years, making it one of the most respected clinical trial businesses in Australia.
Our modern custom-built facility is equipped with 78 inpatient beds and located within Adelaide’s Bio-Med City, providing ready access to state-of-the-art facilities, equipment and world-class medical specialists.
CMAX has a later phase decentralised brand, Fusion Clinical Research.
Australian clinical trials are known for quick start-up timelines, cost competitiveness and quality, with data recognised by the FDA and other regulatory agencies. CMAX’s services are eligible for the generous Australian R&D Tax Incentive scheme.
-
-
ICON
ICON is the world’s leading clinical research organization, powered by healthcare intelligence. From molecule to medicine, we advance clinical research providing outsourced development and commercialization services to pharmaceutical, biotechnology, medical device and government and public health organizations. We develop new innovations, drive emerging therapies forward and improve patient lives. With headquarters in Dublin, Ireland, ICON employed approximately 41,100 employees in 97 locations in 55 countries.
For further information about ICON, visit: www.iconplc.com.
-
Smurfit Westrock
Smurfit Westrock is the go-to sustainable packaging partner of choice. We offer an unrivaled product portfolio and bring expertise, scale and a global presence of 500+ converting operations and 63 mills across 40 countries.
-
Tigermed
Tigermed (Stock code: 300347.SZ/3347.HK) is a leading global provider of integrated research and development solutions for biopharmaceutical and medical device industry. With a broad portfolio of services and a promise of quality, from preclinical development to clinical trial to commercialization, we are collaborating with over 3,200 customers and committed to moving their development journey efficiently and cost-effectively. Tigermed currently represents a worldwide network of more than 180 locations with over 10,000 employees across Asia Pacific, Europe, North America, Latin America and Africa. We are devoted to building an integrated platform that enables the boundless possibilities for the healthcare industry, embracing challenges to fulfill our commitment to serving unmet patients’ needs, and ultimately saving lives.
-
Xincere
Shanghai Xincere Med Tech Inc. is the leading Decentralized Clinical Trial (DCT) platform solution supplier in China, focuses on the development of a patient-centric intelligent platform for remote clinical trials. Powered by the application of digital technology in clinical trials, Xincere strives to improve the accessibility of clinical trials, to alleviate the burden of patients, to advance the quality and efficiency of clinical studies, and to reduce the cost of drug R&D.
Xincere has developed a business line featuring includes: ePData – integrated electric Clinical Outcome Assessment (eCOA) solution, Scale Management, Rater Training, eDiary, eConsent, TeleVisit and so on. With the integrated eCOA solution compatible with local application in China, Xincere now proudly boasts dozens of successful cases of Phase II/III clinical trial projects, and the unprecedented application of remote visit solution in China. Devoted to digital technology development as support for novel drug R&D advancement in China, we hope to help the patients and benefit the society.
-
